August 4, 2022
Mitsubishi Chemical Group is reviewing its business plans around Canadian subsidiary Medicago’s COVID-19 vaccine due to manufacturing process issues and other factors. In line with this, the company will also revisit the current July-September target for its Japan filing. The...read more